or
Bookmark and Share
Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine
   
Document Number
US Patent 6180665
Issued Date
January 30, 2001
Link
Inventors
Map
Abstract
The present invention relates to a crystalline, .alpha.-polymorphic form of a compound of formula (I) and to processes for the preparation of, to intermediates used in the preparation of, to compositions containing and to uses of, the .alpha.-polymorphic form. ##STR1##
Drawing
Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine - US Patent 6180665 Drawing
Drawing from US Patent 6180665
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
18
Comments:
no comments yet
Owner
Pfizer Inc. (New York, NY)
Published
January 30, 2001
Application Number
08/648,001
Filed
May 28, 1996
US Classification
514/533   514/562 560/13 562/430
Int'l Classification
C07C   311/06   (20060101)   C07C   311/00   (20060101)  
Examiner
Assistant Examiner
Priority Data
Dec 04, 1993 [GB] 9324931
USPTO Field of Search
560/13   562/430   514/533   514/562  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us